6.71
-0.06 (-0.89%)
Previous Close | 6.77 |
Open | 6.75 |
Volume | 39,076 |
Avg. Volume (3M) | 74,990 |
Market Cap | 143,026,336 |
Price / Earnings (TTM) | 671.00 |
Price / Sales | 1.30 |
Price / Book | 3.05 |
52 Weeks Range | |
Earnings Date | 5 Nov 2024 - 11 Nov 2024 |
Profit Margin | 1.12% |
Operating Margin (TTM) | 9.24% |
Diluted EPS (TTM) | 0.070 |
Quarterly Revenue Growth (YOY) | 10.70% |
Quarterly Earnings Growth (YOY) | 162.30% |
Total Debt/Equity (MRQ) | 61.92% |
Current Ratio (MRQ) | 1.99 |
Operating Cash Flow (TTM) | 17.19 M |
Levered Free Cash Flow (TTM) | 3.17 M |
Return on Assets (TTM) | 3.33% |
Return on Equity (TTM) | 2.77% |
Market Trend
Short Term | Medium Term | ||
Industry | Medical Instruments & Supplies (US) | Bullish | Mixed |
Medical Instruments & Supplies (Global) | Mixed | Mixed | |
Stock | InfuSystems Holdings, Inc. | - | - |
AIStockmoo Score
Analyst Consensus | 2.0 |
Insider Activity | NA |
Price Volatility | -1.0 |
Technical Moving Averages | 0.0 |
Technical Oscillators | -0.5 |
Average | 0.13 |
InfuSystem Holdings, Inc., through its subsidiaries, provides infusion pumps, and related products and services in the United States and Canada. The company operates in two segments, Integrated Therapy Services (ITS) and Durable Medical Equipment Services (DME Services). It supplies electronic ambulatory infusion pumps and associated disposable supply kits to oncology, infusion, and hospital outpatient chemotherapy clinics for the treatment of various cancers, including colorectal cancer, pain management, and other disease states. The company also sells, rents, and leases new and pre-owned pole-mounted and ambulatory infusion pumps, and other durable medical equipment; sells treatment-related consumables; and provides biomedical recertification, maintenance, and repair services for oncology practices, as well as other healthcare site settings comprising hospitals, home care and home infusion providers, skilled nursing and acute care facilities, pain centers, and others. In addition, it offers local and field-based customer support, as well as operates pump service and repair centers. The company was incorporated in 2005 and is headquartered in Rochester Hills, Michigan. |
|
Sector | Healthcare |
Industry | Medical Instruments & Supplies |
% Held by Insiders | 5.87% |
% Held by Institutions | 77.77% |
Ownership
Name | Date | Shares Held |
---|---|---|
Harbert Fund Advisors, Inc. | 30 Jun 2024 | 618,085 |
No data within this time range.
No data within this time range.
Date | Type | Details |
---|---|---|
03 Dec 2024 | Announcement | Sidoti Events, LLC's Virtual December Small-Cap Conference |
22 Nov 2024 | Announcement | InfuSystem to Present at Sidoti Small Cap Conference on December 4, 2024 |
18 Nov 2024 | Announcement | InfuSystem Appoints Ronald Hundzinski to the Board of Directors |
07 Nov 2024 | Announcement | InfuSystem Reports Third Quarter 2024 Financial Results |
31 Oct 2024 | Announcement | InfuSystem to Report Third Quarter 2024 Financial Results on November 7, 2024 |
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
Realized Profit | - |
Unrealized Profit | - |
Dividend Received 2025 | - |
Total Profit | - |
Avg. Return | - |
Quantity (Buy) | - |
Avg. Price (Buy) | - |
Quantity (Sold) | - |
Avg. Price (Sold) | - |